Mubadala acquires KELIX bio to further advance UAE’s life sciences ecosystem

Mubadala Investment Company PJSC (Mubadala), an Abu Dhabi sovereign investor, has entered into a definitive agreement to acquire KELIX bio, a specialty pharmaceutical business focused on delivering complex generics across emerging markets, to further strengthen the development of the UAE’s life sci